Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2003 2
2004 1
2005 2
2006 1
2007 2
2008 1
2009 6
2010 7
2011 9
2012 10
2013 7
2014 5
2015 6
2016 11
2017 14
2018 16
2019 18
2020 22
2021 25
2022 24
2023 30
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.
Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, Zhan P, Liu X. Xiu S, et al. Among authors: ju h. J Med Chem. 2020 Nov 12;63(21):12256-12274. doi: 10.1021/acs.jmedchem.0c00502. Epub 2020 Jun 25. J Med Chem. 2020. PMID: 32539378 Free PMC article. Review.
Train-of-Four monitoring: overestimation.
Han JU. Han JU. Korean J Anesthesiol. 2011 May;60(5):311-2. doi: 10.4097/kjae.2011.60.5.311. Epub 2011 May 31. Korean J Anesthesiol. 2011. PMID: 21716959 Free PMC article. No abstract available.
Well-demarcated erythematous plaque on the arm.
Song YM, Han JH, Bang CH, Park YM. Song YM, et al. Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):73-75. doi: 10.25259/IJDVL_608_19. Indian J Dermatol Venereol Leprol. 2023. PMID: 34114413 Free article. No abstract available.
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study.
Kim KS, Han KA, Kim TN, Park CY, Park JH, Kim SY, Kim YH, Song KH, Kang ES, Kim CS, Koh G, Kang JG, Kim MK, Han JM, Kim NH, Mok JO, Lee JH, Lim S, Kim SS, Kim TH, Won KC, Lee KY, Cho JH, Han JY, Kim SH, Nah JJ, Song HR, Lee SE, Kim S; ENHANCE-D Investigators. Kim KS, et al. Diabetes Metab. 2023 Jul;49(4):101440. doi: 10.1016/j.diabet.2023.101440. Epub 2023 Mar 9. Diabetes Metab. 2023. PMID: 36906135 Free article. Clinical Trial.
199 results